# Impact of Anti-Giardia and Antihelmintic Treatment on Infant Growth in Bangladesh

> **NCT00607074** · NA · COMPLETED · sponsor: **University of Cambridge** · enrollment: 410 (actual)

## Conditions studied

- Giardiasis

## Interventions

- **DRUG:** Anti-Giardia and antihelmintic treatment (secnidazole or albendazole)
- **DRUG:** Anti-Giardia treatment only (secnidazole or albendazole)
- **DRUG:** Control group (placebo)

## Key facts

- **NCT ID:** NCT00607074
- **Lead sponsor:** University of Cambridge
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2004-04
- **Final completion:** 2006-12
- **Target enrollment:** 410 (ACTUAL)
- **Last updated:** 2008-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00607074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00607074, "Impact of Anti-Giardia and Antihelmintic Treatment on Infant Growth in Bangladesh". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00607074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*